Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
The Prince of Wales visited areas recovering from Hurricane Irma, which battered the British Virgin Islands in September.
Taken in the White Drawing Room at Windsor Castle, a new photograph marks the couple's 70th wedding anniversary.
The 69-year-old republic veteran told the annual Sinn Fein Ard Fheis it would be his last as leader.